STPK - CLDR DOMO PD and UMC among premarket gainers
China HGS Real Estate (HGSH) +164%.Hexindai (HX) +32%.Sutro Biopharma (STRO) +25% as ovarian cancer drug study offers encouraging interim data.Domo (DOMO) +23% on Q3 results.CIIG Merger (CIIC) +22%.Sigma Labs (SGLB) +20%.Collective Growth Corporation (CGRO) +18%.Foresight Autonomous Holdings Ltd. (FRSX) +18% after EC awarded a funding grant of nearly 20M Euro for AWARD.Star Peak Energy Transition (STPK) +18% on announcing business combination with Stem Inc.PagerDuty (PD) +16% on Q3 results.BioCryst Pharmaceuticals (BCRX) +15% as FDA OKs its's Orladeyo to prevent attacks in hereditary angioedema.Xinyuan Real Estate (XIN) +13%.Cloudera (CLDR) +13% on Q3 results.Dunxin Financial Holdings (DXF) +12%.Alaska Communications Systems (ALSK) +12% after superior bid in "Go-Shop" period.United Microelectronics (UMC) +12%.MIND Technology (MIND) +10% on Q3 results.Cocrystal Pharma (COCP) +10%.Inovio Pharmaceuticals (INO) +10%.Amyris (AMRS) +9%.Cerecor (CERC) +8%.Cortexyme (CRTX) +8% as its Alzheimer's med atuzaginstat passes interim tollgate.PDS Biotechnology (PDSB) +7%.Ashford Hospitality Trust (AHT) +7%.WiMi Hologram Cloud (WIMI) +7%.
For further details see:
CLDR, DOMO, PD and UMC among premarket gainers